CALIBERCOS INC-CL A (CWD) Fundamental Analysis & Valuation

NASDAQ:CWD • US13000T6047

Current stock price

1.09 USD
+0.05 (+4.81%)
At close:
1.07 USD
-0.02 (-1.83%)
After Hours:

This CWD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CWD Profitability Analysis

1.1 Basic Checks

  • CWD had negative earnings in the past year.
  • In the past year CWD has reported a negative cash flow from operations.
  • In the past 5 years CWD reported 4 times negative net income.
  • CWD had negative operating cash flow in 4 of the past 5 years.
CWD Yearly Net Income VS EBIT VS OCF VS FCFCWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M

1.2 Ratios

  • The Return On Assets of CWD (-16.10%) is worse than 88.70% of its industry peers.
  • CWD has a Return On Equity of -1635.03%. This is amonst the worse of the industry: CWD underperforms 91.63% of its industry peers.
Industry RankSector Rank
ROA -16.1%
ROE -1635.03%
ROIC N/A
ROA(3y)-12.99%
ROA(5y)-7.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWD Yearly ROA, ROE, ROICCWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CWD Yearly Profit, Operating, Gross MarginsCWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

1

2. CWD Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CWD has been reduced compared to 1 year ago.
  • The number of shares outstanding for CWD has been reduced compared to 5 years ago.
  • CWD has a better debt/assets ratio than last year.
CWD Yearly Shares OutstandingCWD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
CWD Yearly Total Debt VS Total AssetsCWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • CWD has an Altman-Z score of -1.19. This is a bad value and indicates that CWD is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -1.19, CWD is not doing good in the industry: 86.61% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 31.75 is on the high side and indicates that CWD has dependencies on debt financing.
  • With a Debt to Equity ratio value of 31.75, CWD is not doing good in the industry: 91.63% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 31.75
Debt/FCF N/A
Altman-Z -1.19
ROIC/WACCN/A
WACCN/A
CWD Yearly LT Debt VS Equity VS FCFCWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • CWD has a Current Ratio of 0.35. This is a bad value and indicates that CWD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.35, CWD is not doing good in the industry: 80.75% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.35 indicates that CWD may have some problems paying its short term obligations.
  • CWD has a Quick ratio of 0.35. This is amonst the worse of the industry: CWD underperforms 80.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
CWD Yearly Current Assets VS Current LiabilitesCWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

4

3. CWD Growth Analysis

3.1 Past

  • CWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.94%, which is quite impressive.
  • The Revenue for CWD has decreased by -60.69% in the past year. This is quite bad
  • CWD shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.93% yearly.
EPS 1Y (TTM)40.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.84%
Revenue 1Y (TTM)-60.69%
Revenue growth 3Y-37.91%
Revenue growth 5Y-11.93%
Sales Q2Q%-52.46%

3.2 Future

  • The Earnings Per Share is expected to grow by 42.83% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 22.92% on average over the next years. This is a very strong growth
EPS Next Y95.34%
EPS Next 2Y42.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year26.79%
Revenue Next 2Y22.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CWD Yearly Revenue VS EstimatesCWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
CWD Yearly EPS VS EstimatesCWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0 -5 -10 -15

1

4. CWD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CWD. In the last year negative earnings were reported.
  • Also next year CWD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CWD Price Earnings VS Forward Price EarningsCWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CWD Per share dataCWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8 -10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CWD's earnings are expected to grow with 42.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.83%
EPS Next 3YN/A

0

5. CWD Dividend Analysis

5.1 Amount

  • CWD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CWD Fundamentals: All Metrics, Ratios and Statistics

CALIBERCOS INC-CL A

NASDAQ:CWD (5/1/2026, 8:19:39 PM)

After market: 1.07 -0.02 (-1.83%)

1.09

+0.05 (+4.81%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Industry Strength31.68
Industry Growth53.42
Earnings (Last)03-25
Earnings (Next)05-13
Inst Owners2.3%
Inst Owner Change0%
Ins Owners4.52%
Ins Owner Change0%
Market Cap7.68M
Revenue(TTM)20.10M
Net Income(TTM)-21.80M
Analysts80
Price Target7.14 (555.05%)
Short Float %2.99%
Short Ratio2.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-272.44%
Min EPS beat(2)-330.07%
Max EPS beat(2)-214.8%
EPS beat(4)0
Avg EPS beat(4)-433.74%
Min EPS beat(4)-852.97%
Max EPS beat(4)-214.8%
EPS beat(8)1
Avg EPS beat(8)-459.85%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.33%
Min Revenue beat(2)-19.63%
Max Revenue beat(2)-1.03%
Revenue beat(4)1
Avg Revenue beat(4)-8.22%
Min Revenue beat(4)-19.63%
Max Revenue beat(4)3.12%
Revenue beat(8)5
Avg Revenue beat(8)30.62%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B 5.76
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.63
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-1.71
FCFYN/A
OCF(TTM)-1.71
OCFYN/A
SpS2.85
BVpS0.19
TBVpS-6.38
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -16.1%
ROE -1635.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-12.99%
ROA(5y)-7.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 31.75
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z -1.19
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.84%
EPS Next Y95.34%
EPS Next 2Y42.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-60.69%
Revenue growth 3Y-37.91%
Revenue growth 5Y-11.93%
Sales Q2Q%-52.46%
Revenue Next Year26.79%
Revenue Next 2Y22.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y43.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year602.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2273.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2273.87%
OCF growth 3YN/A
OCF growth 5YN/A

CALIBERCOS INC-CL A / CWD Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CALIBERCOS INC-CL A?

ChartMill assigns a fundamental rating of 1 / 10 to CWD.


Can you provide the valuation status for CALIBERCOS INC-CL A?

ChartMill assigns a valuation rating of 1 / 10 to CALIBERCOS INC-CL A (CWD). This can be considered as Overvalued.


Can you provide the profitability details for CALIBERCOS INC-CL A?

CALIBERCOS INC-CL A (CWD) has a profitability rating of 0 / 10.


How financially healthy is CALIBERCOS INC-CL A?

The financial health rating of CALIBERCOS INC-CL A (CWD) is 1 / 10.